202 related articles for article (PubMed ID: 37931855)
1. Therapeutic targets for endometriosis: Genome-wide Mendelian randomization and colocalization analyses.
Zeng P; Lu L; Zhang H; Li Y; Tan S; Yu T; Zhou H
Gene; 2024 Jan; 893():147970. PubMed ID: 37931855
[TBL] [Abstract][Full Text] [Related]
2. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
[TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
4. Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathways.
Adewuyi EO; Mehta D; ; ; Nyholt DR
Hum Reprod; 2022 Jan; 37(2):366-383. PubMed ID: 35472084
[TBL] [Abstract][Full Text] [Related]
5. Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis.
Lin Y; Wang G; Li Y; Yang H; Zhao Y; Liu J; Mu L
J Clin Endocrinol Metab; 2023 Nov; 108(12):3154-3164. PubMed ID: 37350485
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
8. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.
Song W; Li Y; Yao Y; Sun S; Guan X; Wang B
BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983
[TBL] [Abstract][Full Text] [Related]
9. Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.
Ouyang Y; Chen Y; Chen K; Tang Z; Shi G; Qu C; Zhang K; Yang H
Hum Genomics; 2024 Apr; 18(1):43. PubMed ID: 38659056
[TBL] [Abstract][Full Text] [Related]
10. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
11. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization.
Taylor K; Davey Smith G; Relton CL; Gaunt TR; Richardson TG
Genome Med; 2019 Jan; 11(1):6. PubMed ID: 30704512
[TBL] [Abstract][Full Text] [Related]
12. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
14. Tissue specific regulation of transcription in endometrium and association with disease.
Mortlock S; Kendarsari RI; Fung JN; Gibson G; Yang F; Restuadi R; Girling JE; Holdsworth-Carson SJ; Teh WT; Lukowski SW; Healey M; Qi T; Rogers PAW; Yang J; McKinnon B; Montgomery GW
Hum Reprod; 2020 Feb; 35(2):377-393. PubMed ID: 32103259
[TBL] [Abstract][Full Text] [Related]
15. The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study.
Li Y; Liu H; Ye S; Zhang B; Li X; Yuan J; Du Y; Wang J; Yang Y
BMC Med; 2023 May; 21(1):195. PubMed ID: 37226166
[TBL] [Abstract][Full Text] [Related]
16. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
17. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
19. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.
Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT
Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
